偏头痛中重度残疾患者综合管理后预后不良的 影响因素分析
Analysis of Factors Influencing Poor Prognosis after Comprehensive Management of Migraine with Moderate and Severe Disability Patients
DOI: 10.12677/acm.2026.162480, PDF,   
作者: 王雅彬:内蒙古科技大学包头医学院中心临床医学院,内蒙古 包头;潘晓华*:包头市中心医院神经内科,内蒙古 包头;张宇宸:内蒙古医科大学包头临床医学院,内蒙古 包头
关键词: 偏头痛综合管理影响因素预后不良Migraine Comprehensive Management Influencing Factors Poor Prognosis
摘要: 目的:本研究旨在评估综合管理方案对偏头痛中重度残疾患者影响预后不良的因素。方法:收集2022年9月至2024年9月包头市中心医院164例偏头痛患者资料,通过偏头痛残疾程度评估问卷(MIDAS)筛选出中重度障碍组(MIDAS > 10) 98例。收集患者社会人口学信息、头痛特征(病程、发作频率、VAS评分等)及量表数据(MIDAS, MoCA, GAD-7, PHQ-9, PSQI, HIT-6, SF-36)。患者接受综合管理(包括偏头痛日记记录、健康宣教、情绪与睡眠干预、药物治疗指导等),6个月后复查量表,依据MIDAS得分分为预后良好组(≤10)和预后不良组(>10),分析预后不良的影响因素。结果:结果显示,多因素logistic回归分析显示,年龄、PHQ-9量表得分、HIT-6量表得分及SF-36问卷得分与预后不良显著相关。
Abstract: Objective: This study aimed to evaluate factors of poor prognosis in patients with moderate to severe disability from migraine and the impact of a comprehensive management program. Methods: Data of 164 migraine patients from Baotou Central Hospital from September 2022 to September 2024 were collected. The Migraine Disability Assessment Questionnaire (MIDAS), 98 cases of moderate and severe disability group (MIDAS > 10) were screened out. Patients’ socio-demographic information, headache characteristics (course of disease, frequency of attacks, VAS score, etc.) and scale data (MIDAS, MoCA, GAD-7, PHQ-9, PSQI, HIT-6, SF-36) were collected. Patients received comprehensive management (including migraine diary, health education, emotional and sleep intervention, drug treatment guidance, etc.), and the scales were reexamined after 6 months. According to the MIDAS score, patients were divided into a good prognosis group (≤10) and a poor prognosis group (>10), and the factors influencing poor prognosis were analyzed. Results: The results showed that the multi-factor logistic regression analysis showed that age, PHQ-9 score, HIT-6 score and SF-36 questionnaire were significantly associated with poor prognosis.
文章引用:王雅彬, 潘晓华, 张宇宸. 偏头痛中重度残疾患者综合管理后预后不良的 影响因素分析[J]. 临床医学进展, 2026, 16(2): 1003-1011. https://doi.org/10.12677/acm.2026.162480

参考文献

[1] 叶深琼, 王相明, 张月辉. 偏头痛发病机制的研究进展[J]. 医学综述, 2020, 26(6): 1086-1091.
[2] Global Burden of Disease Study 2013 Collaborators (2015) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. Lancet, 386, 743-800.
[3] Vila-Pueyo, M., Gliga, O., Gallardo, V.J. and Pozo-Rosich, P. (2023) The Role of Glial Cells in Different Phases of Migraine: Lessons from Preclinical Studies. International Journal of Molecular Sciences, 24, Article 12553. [Google Scholar] [CrossRef] [PubMed]
[4] Yuasa, G.H., Costa, N.L.V.K., Lopes, R.V., Baggio, D.F., Rae, G.A. and Chichorro, J.G. (2022) Role of Endothelin in the Pathophysiology of Migraine: A New View on an Old Player. Neuropeptides, 96, Article ID: 102286. [Google Scholar] [CrossRef] [PubMed]
[5] Seng, K.E., Hill, J., Reeder, K.A., et al. (2024) Feasibility, Acceptability, and Fidelity of Remote-Delivered Abbreviated Mindfulness-Based Cognitive Therapy Interventions for Patients with Migraine and Depressive Symptoms. Headache, 65, 454-557.
[6] Tuka, B. and Juhasz, G. (2020) Genetics of Migraine: A Complex Disorder with Heterogeneous Clinical Manifestations. FEBS Journal, 287, 236-254.
[7] Chasman, D.I., Schürks, M., Anttila, V., de Vries, B., Schminke, U., Launer, L.J., et al. (2011) Genome-Wide Association Study Reveals Three Susceptibility Loci for Common Migraine in the General Population. Nature Genetics, 43, 695-698. [Google Scholar] [CrossRef] [PubMed]
[8] Anttila, V., Winsvold, B.S., Gormley, P., et al. (2013) Genome-Wide Meta-Analysis Identifies New Susceptibility Loci for Migraine. Nature Genetics, 45, 912-917.
[9] Gormley, P., Anttila, V., Winsvold, B.S., et al. (2016) Meta-Analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine. Nature Genetics, 48, 856-866.
[10] Ferrari, M.D., Haan, J., van den Maagdenberg, A.M., et al. (2015) Genome-Wide Association Analysis in Migraine Implicates Role of Glutamate and Potassium Channels. PLOS Genetics, 11, e1005628.
[11] Victor, T., Hu, X., Campbell, J., Buse, D. and Lipton, R. (2010) Migraine Prevalence by Age and Sex in the United States: A Life-Span Study. Cephalalgia, 30, 1065-1072. [Google Scholar] [CrossRef] [PubMed]
[12] Camerlingo, M., Romorini, A., Ferrante, C., Valente, L. and Moschini, L. (2009) Migraine and Cerebral Infarction in Young People. Neurological Sciences, 31, 293-297. [Google Scholar] [CrossRef] [PubMed]
[13] Raut, S., Singh, U., Sarmah, D., Datta, A., Baidya, F., Shah, B., et al. (2020) Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway. ACS Chemical Neuroscience, 11, 1525-1538. [Google Scholar] [CrossRef] [PubMed]
[14] Caminero, A.B. and Sánchez Del Río González, M. (2012) Migraine as a Cerebrovascular Risk Factor. Neurología (English Edition), 27, 103-111. [Google Scholar] [CrossRef
[15] Togha, M., Nematgorgani, S., Khorsha, F., Mirzaei, K., Mirzababaei, A., Ghorbani, Z., et al. (2021) The Relationship between Major Dietary Patterns and Disease Severity among Migraine Patients. Archives of Neuroscience, 8, e102414. [Google Scholar] [CrossRef
[16] Dirican, N., Demirci, S. and Cakir, M. (2017) The Relationship between Migraine Headache and Asthma Features. Acta Neurologica Belgica, 117, 531-536. [Google Scholar] [CrossRef] [PubMed]
[17] Lantéri-Minet, M. (2000) Analgesic-Induced Chronic Headaches. Pathologie Biologie, 48, 707-714.
[18] Boes, C. and Capobianco, D. (2005) Chronic Migraine and Medication-Overuse Headache through the Ages. Cephalalgia, 25, 378-390. [Google Scholar] [CrossRef] [PubMed]
[19] Ward, T.N. (2004) Medication Overuse Headache. Primary Care: Clinics in Office Practice, 31, 369-380. [Google Scholar] [CrossRef] [PubMed]
[20] Eidlitz-Markus, T., Haimi-Cohen, Y. and Zeharia, A. (2014) Association of Age at Onset of Migraine with Family History of Migraine in Children Attending a Pediatric Headache Clinic: A Retrospective Cohort Study. Cephalalgia, 35, 722-727. [Google Scholar] [CrossRef] [PubMed]
[21] Turan, M.O., Celik Susuz, C. and Turan, P.A. (2017) Presence of Headache and Migraine in Asthma Patients. Turkish Thoracic Journal, 18, 47-51. [Google Scholar] [CrossRef] [PubMed]
[22] Feng, Z., Li, Y., Zou, J., et al. (2011) Analysis of Relationship between Age at Onset and Clinical Features of Migraine. Journal of Shanghai Jiaotong University. Medical Science, 31, 1448-1451.
[23] Tunç, A., Tekeşin, A.K., Güngen, B.D. and Arda, E. (2018) Cognitive Performance in Young and Middle-Aged Adults with Migraine: Investigating the Correlation with White Matter Hyperintensities and Psychological Symptoms. Neurologia i Neurochirurgia Polska, 52, 470-476. [Google Scholar] [CrossRef] [PubMed]
[24] Shin, H.E., Park, J.W., Kim, Y.I. and Lee, K.S. (2008) Headache Impact Test-6 (HIT-6) Scores for Migraine Patients: Their Relation to Disability as Measured from a Headache Diary. Journal of Clinical Neurology, 4, 158-163. [Google Scholar] [CrossRef] [PubMed]
[25] Hussein, M., Hassan, A., Nada, M.A.F., Mohammed, Z., Abdel Ghaffar, N.F., Kedah, H., et al. (2024) Reliability, Validity, and Responsiveness of the Arabic Version of Hit‐6 Questionnaire in Patients with Migraine Indicated for Preventive Therapy: A Multi‐Center Study. Headache: The Journal of Head and Face Pain, 64, 500-508. [Google Scholar] [CrossRef] [PubMed]
[26] Yang, M., Rendas-Baum, R., Varon, S.F. and Kosinski, M. (2010) Validation of the Headache Impact Test (HIT-6™) across Episodic and Chronic Migraine. Cephalalgia, 31, 357-367. [Google Scholar] [CrossRef] [PubMed]
[27] Fuh, J. and Wang, S. (2006) Comparison of Short Form-36 and Migraine Disability Assessment Questionnaire in Patients with Migraine. The Clinical Journal of Pain, 22, 564-568. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, S., Fuh, J., Lu, S. and Juang, K. (2001) Quality of Life Differs among Headache Diagnoses: Analysis of SF-36 Survey in 901 Headache Patients. Pain, 89, 285-292. [Google Scholar] [CrossRef] [PubMed]